Showing posts with label ChemBridge Research Laboratories CRL Pfizer Merck AstraZeneca. Show all posts
Showing posts with label ChemBridge Research Laboratories CRL Pfizer Merck AstraZeneca. Show all posts

Thursday, August 7, 2008

Industry record in turn-around time ultra-fast hit-to-lead libraries


ChemBridge Research Laboratories, Inc. (CRL) announced today that it has established an industry record in turn-around time for hit-to-lead follow-up libraries. Such ultra-fast hit-to-lead libraries are now produced in CRL's San Diego facilities in a matter of three to six days which enables critical acceleration of our clients' medicinal chemistry projects and sets a new industry benchmark. This state-of-the-art high-throughput chemistry technology was developed at CRL over the last seven years and refined in collaborations with Pfizer, Merck, AstraZeneca and others.
Press Release (belga)